MD Atlas

Data last updated: Apr 2025

NEW WAVE LEFT TRIAL FEMUR S2

++M483L091104F9
On MarketClass IIa
RegulationEU MDR
Manufacturergroupe lépine
Primary DI+M483GNAGC1120
ReferenceGNA GC112
View on EUDAMED